NEW YORK (GenomeWeb News) – GE Healthcare and Geron jointly announced today that they will collaborate on developing and selling human embryonic stem cell-based assays for drug discovery, development, and toxicity screening.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.